Skip to main content

Table 3 Response to chemoterapy according to clinical characteristics of patients and histological type of tumor

From: The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients

Patient characteristics Number of patients CR+PR+SD PD
Total Patients 73 61(83.6%) 12 (16.4%)
Sex    
Male 69 58 (84%) 11 (16%)
Female 4 3(75%) 1 (25%)
Stage    
Stage IIIB 30 29(96.6%) 1(3.4%)
Stage IV 43 32 (74.4%) 11 (25.6%)
Histopathology    
Adenocarcinoma 27 21(78%) 6(22%)
Squamous cell (Epidermoid) 34 31(91.2%) 3 (8.8%)
Not otherwise specified (NOS) 12 9 (75%) 3 (25%)